From Foods to Pharmaceuticals, MAHA Strategy Offers Broad Menu of FDA Actions

September 12, 2025 Policy & Regulation, Health Care, Regulatory, Food and Drug Administration (FDA), Life Sciences

The White House’s Make America Healthy Again (MAHA) Commission, led by the Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., released its highly anticipated strategy outlining a multi-agency approach focused on addressing childhood chronic disease. The strategy builds on the Commission’s inaugural health assessment, a report which examined the rising rates of childhood chronic diseases in the country and identified four primary drivers: poor diet due to consumption of ultra-processed foods (UPFs), exposure to environmental chemicals; increased technological use; and overmedicalization. To combat these challenges, the strategy released on September 9, 2025, outlines a four-prong approach which provides further insight into the areas the administration sees as key areas of MAHA going forward: advancing research, realigning incentives, increasing public awareness and fostering private sector collaborations.

Read More

Get the latest FDA and related regulatory developments critical to the life sciences industry delivered to your inbox.

Eye on FDA

A series focused on important FDA and related regulatory developments critical to the life sciences industry.